About Us
Active?
Facet Toggle
June 27, 2022
While there have been high-level commitments from the World Health Assembly, the United Nations General Assembly (UNGA), the G20, and the G7 to tackle AMR, there has yet to be a fundamental change in how we purchase antimicrobials, or an international approach to improving access, fostering innovati...
September 14, 2020
Led by co-chairs Andrew Powell and Liliana Rojas-Suarez, this working group was the result of a collaboration between CGD and the Inter-American Development Bank. The group was formed by international finance experts and Latin-American and the Caribbean policymakers and prepared a report to be ...
October 08, 2019
Learning outcomes are low and instruction is poor in many countries in the Global South. Improving learning outcomes has proven to be difficult, although the number of successful programs is growing. The effective examples have seldom been implemented at large scale, however; and the large-scale suc...
September 14, 2017
A new CGD Working Group is assessing the relevance, advantages and challenges for EMDEs’ growth and development and for the stability of their financial systems derived from the implementation of Basel III. Moreover, the Group is advancing specific recommendations regarding components of Basel...
January 23, 2015
The Unintended Consequences of Rich Countries’ Anti-Money Laundering Policies on Poor Countries Working Group examined how rich countries might rebalance their policies to continue to protect against money laundering and terrorism financing without hindering the ability of people from poor countries...
November 25, 2014
In many large federal or decentralized countries, the majority of public spending on health is executed by state and district governments (see graph below). Improving health in these countries—and globally—depends on improving the sufficiency, efficiency, and effectiveness of health spendi...
August 25, 2014
As international commitments become more ambitious and aid resources become increasingly constrained, global health funding agencies are seeking to improve the efficiency and impact of their investments. This growing “value for money” (VfM) agenda aims to reduce costs, increase imp...